Psychostimulant properties of MDMA.
Gold
L H
LH
Department of Neuropharmacology, Research Institute of Scripps Clinic, La Jolla, CA 92037.
Geyer
M A
MA
Koob
G F
GF
D015104:3,4-Methylenedioxyamphetamine / Q000031:analogs & derivatives / Q000494:pharmacology*; D000662:Amphetamines / Q000494:pharmacology*; D000818:Animals; D001143:Arousal / Q000187:drug effects*; D001921:Brain / Q000187:drug effects; D015198:Designer Drugs; D004305:Dose-Response Relationship, Drug; D009043:Motor Activity / Q000187:drug effects*; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects; D011985:Receptors, Serotonin / Q000187:drug effects
D000662:Amphetamines; D015198:Designer Drugs; D011954:Receptors, Dopamine; D011985:Receptors, Serotonin; D015104:3,4-Methylenedioxyamphetamine; D018817:N-Methyl-3,4-methylenedioxyamphetamine